Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Research & Development: 2009-2024

Historic Research & Development for Assembly Biosciences (ASMB) over the last 14 years, with Dec 2024 value amounting to $55.9 million.

  • Assembly Biosciences' Research & Development rose 22.73% to $16.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.8 million, marking a year-over-year increase of 17.44%. This contributed to the annual value of $55.9 million for FY2024, which is 14.38% up from last year.
  • Latest data reveals that Assembly Biosciences reported Research & Development of $55.9 million as of FY2024, which was up 14.38% from $48.9 million recorded in FY2023.
  • Over the past 5 years, Assembly Biosciences' Research & Development peaked at $106.8 million during FY2020, and registered a low of $48.9 million during FY2023.
  • Its 3-year average for Research & Development is $58.3 million, with a median of $55.9 million in 2024.
  • As far as peak fluctuations go, Assembly Biosciences' Research & Development increased by 24.56% in 2020, and later plummeted by 35.85% in 2021.
  • Assembly Biosciences' Research & Development (Yearly) stood at $106.8 million in 2020, then slumped by 35.85% to $68.5 million in 2021, then grew by 2.12% to $70.0 million in 2022, then tumbled by 30.12% to $48.9 million in 2023, then climbed by 14.38% to $55.9 million in 2024.